The determination of IgA-bound specific intestinal taxa in MS patients and experiments in animal models indicate an immunomodulatory function of IgA-producing B cells that receive their imprinting in the intestine and migrate to the CNS (50, 51). Here, CD79A is linked to myeloid sarcoma.